Kevin Gorman | Chief Executive Officer |
Todd Tushla | Head-Investor Relations |
Matt Abernethy | Chief Financial Officer |
Eric Benevich | Chief Commercial Officer |
Eiry Roberts | Chief Medical Officer |
Kyle Gano | Chief Business Development Officer |
Paul Matteis | Stifel |
Biren Amin | Jefferies LLC |
Jack Allen | Baird |
Anupam Rama | JPMorgan |
Jay Olsen | Oppenheimer |
Charles Duncan | Cantor |
Phil Nadeau | Cowen and Company |
Vamil Divan | Mizuho Securities |
Carter Gould | Barclays |
Evan Seigerman | Credit Suisse |
Tazeen Ahmad | Bank of America |
Good day, everyone, and welcome to today's Neurocrine Bioscineces Report Q1 2020 Results Call. At this time, all participants are in a listen-only mode. Later, you'll have the opportunity to ask questions during the question-and-answer session. [Operator Instructions] Please note, this call may be recorded. I'll be standing by should you need assistance.